We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+0.8%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.47B
AUM Growth
-$224M
Cap. Flow
-$207M
Cap. Flow %
-5.98%
Top 10 Hldgs %
42.55%
Holding
402
New
36
Increased
195
Reduced
128
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 15.15%
2 Healthcare 5.85%
3 Financials 4.74%
4 Communication Services 3.24%
5 Industrials 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPL icon
101
Texas Pacific Land
TPL
$27.8B
$4.86M 0.14%
13,188
-147
-1% -$60.1K
VEA icon
102
Vanguard FTSE Developed Markets ETF
VEA
$229B
$4.77M 0.14%
99,744
-44,577
-31% -$2.24M
GSK icon
103
GSK
GSK
$104B
$4.73M 0.14%
+139,875
New +$5.04M
JHMM icon
104
John Hancock Multifactor Mid Cap ETF
JHMM
$5.92B
$4.68M 0.13%
78,352
+260
+0.3% +$16K
AVLC icon
105
Avantis US Large Cap Equity ETF
AVLC
$1.37B
$4.59M 0.13%
68,012
+58,438
+610% +$3.99M
LEA icon
106
Lear
LEA
$6.54B
$4.44M 0.13%
46,898
-13,416
-22% -$1.34M
TXN icon
107
Texas Instruments
TXN
$252B
$4.28M 0.12%
22,849
+653
+3% +$131K
VBK icon
108
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
$4.25M 0.12%
15,179
+36
+0.2% +$10.2K
HYG icon
109
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$4.23M 0.12%
53,762
+2,893
+6% +$230K
BIIB icon
110
Biogen
BIIB
$30B
$3.92M 0.11%
25,613
-21,854
-46% -$3.69M
SUSA icon
111
iShares ESG Optimized MSCI USA ETF
SUSA
$4.01B
$3.63M 0.1%
29,890
-120
-0.4% -$14.7K
SPSM icon
112
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.1B
$3.54M 0.1%
78,739
+1,210
+2% +$56.3K
IBM icon
113
IBM
IBM
$211B
$3.51M 0.1%
15,988
+65
+0.4% +$14.5K
VDC icon
114
Vanguard Consumer Staples ETF
VDC
$7.97B
$3.5M 0.1%
+16,566
New +$3.59M
MCD icon
115
McDonald's
MCD
$192B
$3.49M 0.1%
12,037
-74
-0.6% -$22.1K
IBB icon
116
iShares Biotechnology ETF
IBB
$9.34B
$3.46M 0.1%
+26,182
New +$3.68M
IYK icon
117
iShares US Consumer Staples ETF
IYK
$1.4B
$3.23M 0.09%
+49,289
New +$3.39M
BINC icon
118
BlackRock Flexible Income ETF
BINC
$16.1B
$3.23M 0.09%
+62,138
New +$3.27M
LLY icon
119
Eli Lilly
LLY
$1.02T
$3.21M 0.09%
4,152
+79
+2% +$65.4K
DIA icon
120
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
$3.18M 0.09%
7,465
+122
+2% +$52.8K
SPEM icon
121
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.2B
$3.15M 0.09%
82,154
-896
-1% -$36K
TXT icon
122
Textron
TXT
$14.7B
$3.13M 0.09%
76,350
+31
+0% +$2.6K
QQQ icon
123
Invesco QQQ Trust
QQQ
$453B
$3.06M 0.09%
5,977
-363
-6% -$184K
IEO icon
124
iShares US Oil & Gas Exploration & Production ETF
IEO
$580M
$2.99M 0.09%
33,316
+96
+0.3% +$9.04K
SYK icon
125
Stryker
SYK
$125B
$2.98M 0.09%
8,277
+38
+0.5% +$14.1K

Similar funds

Grimes & Company's Q4 2024 Portfolio in Review

As of Q4 2024, Grimes & Company held 402 positions worth $3.47B, down 6.1% from $3.7B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Grimes & Company withdrew a net $207M in Q4 2024, closing 22 positions and reducing 128 holdings. Its most notable exit was Trinity Capital Inc., an estimated $668K position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grimes & Company opened a new position in Constellation Brands worth $6.1M.

  • Grimes & Company's largest Q4 2024 buy was Constellation Brands: 27,600 shares worth $6.1M.
  • Grimes & Company added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2024, an estimated $18.8M increase.
  • Grimes & Company's biggest Q4 2024 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $245M.
  • Grimes & Company fully exited Trinity Capital Inc. in Q4 2024, selling an estimated $668K.
  • Grimes & Company's ten largest holdings make up 43% of its $3.47B portfolio in Q4 2024.
  • Grimes & Company opened 36 new positions and closed 22 in Q4 2024.
  • Grimes & Company's portfolio value fell 6.1% quarter-over-quarter to $3.47B.

Based on Grimes & Company's 13F filing for Q4 2024, filed 21 Jan 2025.